Adding a LAMA to Salmeterol/Fluticasone Improves COPD Lung FunctionAdding a LAMA to Salmeterol/Fluticasone Improves COPD Lung Function
Adding a once-a-day long-acting muscarinic antagonist (LAMA) to salmeterol/fluticasone propionate (SAL/FP) improves outcomes in chronic obstructive pulmonary disease (COPD), according to a report from Australia and New Zealand. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 8, 2015 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Breo Ellipta Approved for Asthma (FREE)
By the Editors The FDA has approved fluticasone furoate/vilanterol (Breo Ellipta) for use in adults who have severe asthma or asthma that is not … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 4, 2015 Category: Primary Care Source Type: news

FDA Okays Breo Ellipta for Asthma in AdultsFDA Okays Breo Ellipta for Asthma in Adults
The once-daily treatment combines the inhaled corticosteroid fluticasone furoate and the long-acting beta2-agonist vilanterol. FDA Approvals (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 1, 2015 Category: Primary Care Tags: Pulmonary Medicine News Alert Source Type: news

GSK and Theravance receive FDA approval for asthma drug Breo Ellipta
GlaxoSmithKline (GSK) and Theravance have received approval from the US Food and Drug Administration (FDA) for the Breo Ellipta (fluticasone furoate/vilanterol [FF/VI]) as the once-daily treatment for asthma patients aged 18 years and older. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 30, 2015 Category: Pharmaceuticals Source Type: news

azelastine hydrochloride and fluticasone propionate (Dymista)
Title: azelastine hydrochloride and fluticasone propionate (Dymista)Category: MedicationsCreated: 4/20/2015 12:00:00 AMLast Editorial Review: 4/20/2015 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - April 20, 2015 Category: Allergy & Immunology Source Type: news

fluticasone (Flonase, Flonase Allergy Relief)
Title: fluticasone (Flonase, Flonase Allergy Relief)Category: MedicationsCreated: 3/26/1998 12:00:00 AMLast Editorial Review: 4/14/2015 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - April 14, 2015 Category: Allergy & Immunology Source Type: news

fluticasone (Flonase)
Title: fluticasone (Flonase)Category: MedicationsCreated: 3/26/1998 12:00:00 AMLast Editorial Review: 2/20/2015 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - February 20, 2015 Category: Allergy & Immunology Source Type: news

Lupin and Celon Pharma partner for generic version of GSK’s Advair Diskus
India-based drugmaker Lupin has signed an agreement with Polish biopharmaceutical firm Celon Pharma to develop a fluticasone / salmeterol dry powder inhaler (DPI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 18, 2015 Category: Pharmaceuticals Source Type: news

Is A Specific Corticosteroid Better for Treatment of Asthma Than Another?
Discussion Asthma is a chronic obstructive lung disease that affects many children and adults. There is a wide range of symptoms that people experience from occurring relatively rarely (ie intermittent asthma) to patients having daily symptoms of such intensity that they are life-threatening (ie chronic severe asthma). The goals of asthma management include patient education and medication management so patients have no or minimal symptoms, prevent exacerbations, have no activity restrictions, have normal pulmonary function tests, have no or minimal medication side effects and meet patient and family expectations. Well con...
Source: PediatricEducation.org - January 5, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Triple Therapy Tied to Reduced Rate of COPD Exacerbations
Benefits seen for triple therapy with fluticasone furoate, umeclidinium, and vilanterol (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Fluticasone Furoate for Asthma in Adults and AdolescentsFluticasone Furoate for Asthma in Adults and Adolescents
Inhaled corticosteroids are a mainstay of therapy for persistent asthma, but suboptimal adherence with twice-daily use is widespread. BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 3, 2014 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Mundipharma reports Phase III flutiform trial results in paediatric asthma
Mundipharma has reported results from a randomised, multicentre, Phase III trial of flutiform, a combination of fluticasone propionate and formoterol in a single pressurised metered dose inhaler, to treat paediatric asthma. (Source: Drug Development Technology)
Source: Drug Development Technology - September 8, 2014 Category: Pharmaceuticals Source Type: news

Novartis data show once-daily Ultibro® Breezhaler® is superior in COPD
Novartis presented new data that demonstrated once-daily Ultibro® Breezhaler® (indacaterol/glycopyrronium bromide) was superior in reducing exacerbations (flare ups) and improving lung function compared to twice-daily Seretide®Accuhaler®* (salmeterol/fluticasone (SFC)), in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 8, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Respiratory copd exacerbation indacaterol/glycopyrronium bromide Latest News lung function Source Type: news

Cipla introduces Serroflo for respiratory treatment in Germany and Sweden
India-based Cipla has introduced Serroflo (salmeterol/fluticasone MDI) in Germany and Sweden to treat patients suffering from asthma. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 2, 2014 Category: Pharmaceuticals Source Type: news

Arnuity Ellipta (Fluticasone Furoate Inhalation Powder) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2014 Category: Drugs & Pharmacology Source Type: news